1S20
A novel NAD binding protein revealed by the crystal structure of E. Coli 2,3-diketogulonate reductase (YiaK) NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER82
Summary for 1S20
Entry DOI | 10.2210/pdb1s20/pdb |
Related | 1NXU |
Descriptor | Hypothetical oxidoreductase yiaK, L(+)-TARTARIC ACID, NICOTINAMIDE-ADENINE-DINUCLEOTIDE, ... (4 entities in total) |
Functional Keywords | alpha beta dimeric protein, oxidoreductase, structural genomics, psi-2, protein structure initiative, northeast structural genomics consortium, nesg |
Biological source | Escherichia coli |
Cellular location | Cytoplasm (Potential): P37672 |
Total number of polymer chains | 8 |
Total formula weight | 311962.73 |
Authors | Forouhar, F.,Lee, I.,Benach, J.,Kulkarni, K.,Xiao, R.,Acton, T.B.,Montelione, G.T.,Tong, L.,Northeast Structural Genomics Consortium (NESG) (deposition date: 2004-01-07, release date: 2004-01-20, Last modification date: 2023-11-15) |
Primary citation | Forouhar, F.,Lee, I.,Benach, J.,Kulkarni, K.,Xiao, R.,Acton, T.B.,Montelione, G.T.,Tong, L. A Novel NAD-binding Protein Revealed by the Crystal Structure of 2,3-Diketo-L-gulonate Reductase (YiaK). J.Biol.Chem., 279:13148-13155, 2004 Cited by PubMed Abstract: Escherichia coli YiaK catalyzes the reduction of 2,3-diketo-L-gulonate in the presence of NADH. It belongs to a large family of oxidoreductases that is conserved in archaea, bacteria, and eukaryotes but shows no sequence homology to other proteins. We report here the crystal structures at up to 2.0-A resolution of YiaK alone and in complex with NAD-tartrate. YiaK has a new polypeptide backbone fold and a novel mode of recognizing the NAD cofactor. In addition, NAD is bound in an unusual conformation, at the interface of a dimer of the enzyme. The crystallographic analysis unexpectedly revealed the binding of tartrate in the active site. Enzyme kinetics studies confirm that tartrate and the related D-malate are inhibitors of YiaK. In contrast to most other enzymes where substrate binding produces a more closed conformation, the binding of NAD-tartrate to YiaK produces a more open active site. The free enzyme conformation is incompatible with NAD binding. His(44) is likely the catalytic residue of the enzyme. PubMed: 14718529DOI: 10.1074/jbc.M313580200 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report